Charles Mallender

1.2k total citations
25 papers, 804 citations indexed

About

Charles Mallender is a scholar working on Cardiology and Cardiovascular Medicine, Internal Medicine and Epidemiology. According to data from OpenAlex, Charles Mallender has authored 25 papers receiving a total of 804 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Cardiology and Cardiovascular Medicine, 2 papers in Internal Medicine and 2 papers in Epidemiology. Recurrent topics in Charles Mallender's work include Atrial Fibrillation Management and Outcomes (23 papers), Cardiac Arrhythmias and Treatments (14 papers) and Cardiac pacing and defibrillation studies (5 papers). Charles Mallender is often cited by papers focused on Atrial Fibrillation Management and Outcomes (23 papers), Cardiac Arrhythmias and Treatments (14 papers) and Cardiac pacing and defibrillation studies (5 papers). Charles Mallender collaborates with scholars based in United States and Australia. Charles Mallender's co-authors include Heidi T. May, Brian G. Crandall, Jeffrey S. Osborn, T. Jared Bunch, J. Peter Weiss, John Day, Tami L. Bair, Michael J. Cutler, Victoria Jacobs and Jeffrey L. Anderson and has published in prestigious journals such as Circulation, The American Journal of Cardiology and American Heart Journal.

In The Last Decade

Charles Mallender

25 papers receiving 783 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Charles Mallender United States	15	749	192	60	58	53	25	804
Agnes Pump United States	10	1.1k 1.5×	103 0.5×	29 0.5×	49 0.8×	28 0.5×	14	1.2k
Yan‐Guang Li China	16	669 0.9×	133 0.7×	25 0.4×	45 0.8×	27 0.5×	38	763
Josep Lluís Clua‐Espuny Spain	10	253 0.3×	120 0.6×	22 0.4×	42 0.7×	18 0.3×	45	369
Louisa Christensen Denmark	9	211 0.3×	172 0.9×	10 0.2×	70 1.2×	50 0.9×	22	358
Dimitrios Sagris Greece	11	250 0.3×	193 1.0×	10 0.2×	152 2.6×	118 2.2×	45	483
Giovanni Luca Botto Italy	19	1.5k 2.1×	86 0.4×	26 0.4×	30 0.5×	61 1.2×	78	1.6k
Alexandre Bodin France	13	402 0.5×	104 0.5×	18 0.3×	33 0.6×	12 0.2×	54	478
Megan Meredith Australia	7	1.2k 1.5×	70 0.4×	55 0.9×	42 0.7×	17 0.3×	12	1.3k
Belinda Sandler United Kingdom	13	267 0.4×	41 0.2×	30 0.5×	34 0.6×	13 0.2×	35	379
Olivier Piot France	16	872 1.2×	37 0.2×	55 0.9×	22 0.4×	50 0.9×	56	949

Countries citing papers authored by Charles Mallender

Since Specialization

Citations

This map shows the geographic impact of Charles Mallender's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Charles Mallender with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Charles Mallender more than expected).

Fields of papers citing papers by Charles Mallender

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Charles Mallender. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Charles Mallender. The network helps show where Charles Mallender may publish in the future.

Co-authorship network of co-authors of Charles Mallender

This figure shows the co-authorship network connecting the top 25 collaborators of Charles Mallender. A scholar is included among the top collaborators of Charles Mallender based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Charles Mallender. Charles Mallender is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Cutler, Michael J., Tami L. Bair, Brian G. Crandall, et al.. (2024). PO-04-055 CLINICAL, ECONOMIC AND HEALTHCARE UTILIZATION IMPACT OF EARLY AMBULATION USING PROGLIDE VENOUS CLOSURE FOLLOWING ATRIAL FIBRILLATION ABLATION. Heart Rhythm. 21(5). S476–S476. 1 indexed citations

Cutler, Michael J., Heidi T. May, Tami L. Bair, et al.. (2022). Atrial fibrillation is a risk factor for major adverse cardiovascular events in COVID-19. IJC Heart & Vasculature. 43. 101127–101127. 10 indexed citations

Bunch, T. Jared, Heidi T. May, Tami L. Bair, et al.. (2019). Long-term outcomes after low power, slower movement versus high power, faster movement irrigated-tip catheter ablation for atrial fibrillation. Heart Rhythm. 17(2). 184–189. 48 indexed citations

Bunch, T. Jared, Tami L. Bair, Brian G. Crandall, et al.. (2019). Stroke and dementia risk in patients with and without atrial fibrillation and carotid arterial disease. Heart Rhythm. 17(1). 20–26. 24 indexed citations

Bunch, T. Jared, Victoria Jacobs, Heidi T. May, et al.. (2019). Rationale and design of the impact of anticoagulation therapy on the Cognitive Decline and Dementia in Patients with Nonvalvular Atrial Fibrillation (CAF) Trial: A Vanguard study. Clinical Cardiology. 42(5). 506–512. 10 indexed citations

May, Heidi T., Tami L. Bair, Victoria Jacobs, et al.. (2018). The Impact of Gender on Atrial Fibrillation Incidence and Progression to Dementia. The American Journal of Cardiology. 122(9). 1489–1495. 7 indexed citations

May, Heidi T., Tami L. Bair, Victoria Jacobs, et al.. (2017). The Population-Based Long-Term Impact of Anticoagulant and Antiplatelet Therapies in Low-Risk Patients With Atrial Fibrillation. The American Journal of Cardiology. 120(1). 75–82. 4 indexed citations

May, Heidi T., Victoria Jacobs, Tami L. Bair, et al.. (2017). Atrial fibrillation incrementally increases dementia risk across all CHADS2 and CHA2DS2VASc strata in patients receiving long-term warfarin. American Heart Journal. 188. 93–98. 35 indexed citations

Jacobs, Victoria, Heidi T. May, Tami L. Bair, et al.. (2017). Long‐term aspirin does not lower risk of stroke and increases bleeding risk in low‐risk atrial fibrillation ablation patients. Journal of Cardiovascular Electrophysiology. 28(11). 1241–1246. 2 indexed citations

10.

Bunch, T. Jared, Heidi T. May, Tami L. Bair, et al.. (2016). Long-term influence of body mass index on cardiovascular events after atrial fibrillation ablation. Journal of Interventional Cardiac Electrophysiology. 46(3). 259–265. 27 indexed citations

11.

Jacobs, Victoria, Heidi T. May, Tami L. Bair, et al.. (2016). Long-Term Population-Based Cerebral Ischemic Event and Cognitive Outcomes of Direct Oral Anticoagulants Compared With Warfarin Among Long-term Anticoagulated Patients for Atrial Fibrillation. The American Journal of Cardiology. 118(2). 210–214. 111 indexed citations

12.

Bunch, T. Jared, Heidi T. May, Tami L. Bair, et al.. (2016). Atrial Fibrillation Patients Treated With Long‐Term Warfarin Anticoagulation Have Higher Rates of All Dementia Types Compared With Patients Receiving Long‐Term Warfarin for Other Indications. Journal of the American Heart Association. 5(7). 35 indexed citations

13.

Weiss, J. Peter, Heidi T. May, Tami L. Bair, et al.. (2016). A Comparison of Remote Magnetic Irrigated Tip Ablation versus Manual Catheter Irrigated Tip Catheter Ablation With and Without Force Sensing Feedback. Journal of Cardiovascular Electrophysiology. 27(S1). S5–S10. 22 indexed citations

14.

Jacobs, Victoria, Heidi T. May, Tami L. Bair, et al.. (2015). Abstract 11938: Long-term Population-based Outcomes of Novel Oral Anticoagulants Compared to Warfarin Among Long-term Anticoagulated Patients: A Propensity Matched Analysis. Circulation. 132(suppl_3). 1 indexed citations

15.

Jacobs, Victoria, Scott C. Woller, Scott M. Stevens, et al.. (2015). Percent Time With a Supratherapeutic INR in Atrial Fibrillation Patients Also Using an Antiplatelet Agent Is Associated With Long‐Term Risk of Dementia. Journal of Cardiovascular Electrophysiology. 26(11). 1180–1186. 32 indexed citations

16.

Bunch, T. Jared, Heidi T. May, Tami L. Bair, et al.. (2015). The Impact of Age on 5‐Year Outcomes After Atrial Fibrillation Catheter Ablation. Journal of Cardiovascular Electrophysiology. 27(2). 141–146. 47 indexed citations

17.

Bunch, T. Jared, Heidi T. May, Tami L. Bair, et al.. (2015). Long-Term Natural History of Adult Wolff–Parkinson–White Syndrome Patients Treated With and Without Catheter Ablation. Circulation Arrhythmia and Electrophysiology. 8(6). 1465–1471. 22 indexed citations

18.

Jacobs, Victoria, Scott C. Woller, Scott M. Stevens, et al.. (2014). Time outside of therapeutic range in atrial fibrillation patients is associated with long-term risk of dementia. Heart Rhythm. 11(12). 2206–2213. 118 indexed citations

19.

Jacobs, Victoria, Heidi T. May, Tami L. Bair, et al.. (2014). The impact of risk score (CHADS2 versus CHA2DS2-VASc) on long-term outcomes after atrial fibrillation ablation. Heart Rhythm. 12(4). 681–686. 72 indexed citations

20.

Bunch, T. Jared, J. Peter Weiss, Brian G. Crandall, et al.. (2013). Patients treated with catheter ablation for ventricular tachycardia after an ICD shock have lower long-term rates of death and heart failure hospitalization than do patients treated with medical management only. Heart Rhythm. 11(4). 533–540. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact